Home
Site Search
Use small fonts Use medium fonts Use large fonts Email link to page

Jonathan Sherman Picture

Email to Jonathan Sherman Jonathan Sherman

Partner

OfficeToronto

t: 416 869 5409
f: 416 640 3136
e: send email

Suite 2100, Scotia Plaza
40 King Street West
Toronto, ON  M5H 3C2
Canada

Download vCard

Bio

Expertise

Year of Call

Ontario, 2015

Education

J.D., Osgoode Hall Law School

B.Com., McGill University

Jonathan Sherman

Recent Work

Canopy Growth Implements Plan of Arrangement to Acquire U.S. Multi-State Cannabis Operator Acreage Holdings 2019
Canopy Growth Announces Acquisition of KeyLeaf Life Sciences 2019
Canopy Growth Enters into Multi-Year Manufacturing Agreement with Procaps 2019
Canopy Growth Announces Offtake Agreement with PharmHouse 2019
Canopy Growth Announces Plan to Acquire Leading U.S. Multi-State Cannabis Operator, Acreage Holdings for US$3.4 Billion 2019
Cassels Brock Represents the Underwriters in 48North's $28.75 Million Financing 2019
Canopy Growth Enters into Multi-Year Extraction Agreement with HollyWeed 2019
Canopy Rivers and LeafLink Collaborate to Deploy Market-Leading B2B Software Platform Globally 2019
Canopy Growth, NHL Alumni Association and NEEKA Healthcare Canada Announce Transformative Research Initiative 2019
Canopy Rivers Completes $93.5 Million Concurrent Financings; First Cannabis Industry Financing to include Three of Five Largest Canadian Banks 2019
Canopy Growth Partners with Alimentation Couche Tard & Announces Tweed Branded Retail Store in Ontario 2019
Canopy Rivers Announces Bought Deal Financing and Investment From Canopy Growth for Total Gross Proceeds of $85 Million 2019
Canopy Rivers Completes Investment in Adult-Use Cannabis Beverage and Edibles Brand 2019
Canopy Rivers Completes Investment in Greenhouse Juice Company 2019
Canopy Rivers Completes Investment in Technology Driven Data Company Headset 2019
PharmHouse Completes $80 Million Bank Debt Facility, One of the First Syndicated Debt Deals in the Cannabis Industry 2019
Canopy Growth Enters into Multi-year Extraction Agreement with Valens GroWorks 2018
Canopy Rivers Furthers Investment in Italy 2018
Canopy Growth Announces Strategic Equity Investment and Supply Deal with 48North 2018
Canopy Growth and Canopy Rivers Complete TerrAscend Restructuring 2018
Canopy Growth Completes Strategic Extract Supply Agreement with MediPharm Labs 2018
Canopy Growth and Battelle Announce Strategic Collaboration to Advance Cannabis Research 2018
Canopy Rivers Enters into $40 Million Funding Agreement with PharmHouse Inc. 2018
Canopy Growth and Brink's Announce Partnership 2018
Canopy Rivers Completes Go-Public Transaction 2018
Canopy Growth and Centric Health Enter into Strategic Partnership 2018
Canopy Growth Completes $540 Million Acquisition of Hiku Brands 2018
Canopy Growth Announces Further Consolidation of Latin America Assets 2018
Canopy Rivers Raises $104 Million and Enters Definitive Agreement to Complete Reverse Take-Over 2018
Canopy Growth Announces Latin American Subsidiary Canopy LATAM and Acquisition of Spectrum Cannabis Colombia S.A.S. and Canindica Capital Ltd. 2018
Canopy Growth Completes $375 Million Acquisition of Remaining 33% of BC Tweed 2018
Canopy Growth Completes $500 Million Offering, the Largest Financing to Date in the Cannabis Industry 2018
Canopy Growth Enters Agreement with Neptune Technologies & Bioressources to Provide Extracted Cannabis Products 2018
Canopy Rivers Announces Go-Public Transaction and Financing co-led by CIBC Capital Markets, GMP Securities and Eight Capital 2018
Canopy Growth Acquires Annabis Medical, the Largest Medical Cannabis Company in the Czech Republic 2018
Canopy Rivers Closes Oversubscribed $26 Million Private Placement 2018
Canopy Growth Announces Joint Venture to Convert 700,000 Square Feet of Existing Greenhouse in Quebec 2017
Canopy and JW Asset Management Announce Strategic Investment in TerrAscend Corp. 2017
Canopy Growth Establishes Joint Venture to Convert 1.3 Million Square Feet of Existing Greenhouse in British Columbia 2017
Canopy Growth Solidifies New Brunswick Expansion Strategy with the Acquisition of Spot Therapeutics Inc. 2017